FDA Panel Signs Off
On Stimulant ADHD Study

WASHINGTON -- An outside panel of medical experts recommended Wednesday that the Food and Drug Administration allow researchers to proceed with a study that would give healthy children a stimulant.

The study by the National Institutes of Health, designed to help researchers learn more about attention deficit hyperactivity disorder, would also give the stimulant to children diagnosed with ADHD, the most common behavioral disorder in...